SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Jemal A,Siegel R,Ward E,Murray T,Xu J,Thun M. Cancer statistics, 2007. CA Cancer J Clin. 2007; 57: 4366.
  • 2
    Smith RA,Cokkinides V,Eyre HJ. Cancer screening in the United States, 2007: a review of current guidelines, practices and prospects. CA Cancer J Clin. 2007; 57: 90104.
  • 3
    Winawer S,Fletcher R,Rex D, et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale — update based on new evidence. Gastroenterology. 2003; 124: 544560.
  • 4
    United States Preventive Services Task Force. Screening for colorectal cancer: recommendations and rationale. Ann Intern Med. 2002; 137: 129131.
  • 5
    Rex DK,Johnson DA,Lieberman DA,Burt RW,Sonnenberg A. Colorectal cancer prevention 2000: screening recommendations of the American College of Gastroenterology. Am J Gastroenterol. 2000; 95: 868877.
  • 6
    Health Care Financing Administration. Medicare coverage of colorectal cancer screening. Transmittal No. AB-97–24. Washington, DC: Health Care Financing Administration; 1997.
  • 7
    Health Care Financing Administration. Billing for colorectal screening. Transmittal No. 769. Washington, DC: Health Care Financing Administration; 2001.
  • 8
    U.S. Department of Health and Human Services. Healthy People 2010: Understanding and Improving Health. Washington, DC: U.S. Department of Health and Human Services; 2000.
  • 9
    Centers for Disease Control and Prevention. Increased use of colorectal cancer tests—United States, 2002 and 2004. MMWR Morb Mortal Wkly Rep. 2006; 55: 308311.
  • 10
    Phillips KA,Liang S,Ladabaum U, et al. Trends in colonoscopy for colorectal cancer screening. Med Care. 2007; 45: 160167.
  • 11
    Winawer SJ,Zauber AG,Fletcher RH, et al. Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the U.S. Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. Gastroenterology. 2006; 130: 18721885.
  • 12
    Potosky AL,Riley GF,Lubitz JD,Mentnech RM,Kessler LG. Potential for cancer related health services research using a linked Medicare-tumor registry database. Med Care. 1993; 31: 732748.
  • 13
    Warren JL,Klabunde CN,Schrag D,Bach PB,Riley GF. Overview of the SEER-Medicare data. Med Care. 2002; 40: IV-3IV-18.
  • 14
    Charlson ME,Pompei P,Ales KL,MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis. 1987; 40: 373383.
  • 15
    Deyo RA,Cherkin DC,Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992; 45: 613619.
  • 16
    Chu KC,Tarone RE,Chow W-H,Hankey BF,Ries LAG. Temporal patterns in colorectal cancer incidence, survival, and mortality from 1950 through 1990. J Natl Cancer Inst. 1994; 86: 9971006.
  • 17
    Ko CW,Sonnenberg A. Comparing risks and benefits of colorectal cancer screening in elderly patients. Gastroenterology. 2005; 129: 11631170.
  • 18
    Lin OS,Kozarek RA,Schembre DB, et al. Screening colonoscopy in very elderly patients: prevalence of neoplasia and estimated impact on life expectancy. JAMA. 2006; 295: 23572365.
  • 19
    Ko CW,Kreuter W,Baldwin L-M. Effect of Medicare coverage on use of invasive colorectal cancer screening tests. Arch Intern Med. 2002; 162: 25812586.
  • 20
    Richards RJ,Reker DM. Racial differences in use of colonoscopy, sigmoidoscopy and barium enema in Medicare beneficiaries. Dig Dis Sci. 2002; 47: 27152719.
  • 21
    Ananthakrishnan AN,Schellhase KG,Sparapani RA,Laud PW,Neuner JM. Disparities in colon cancer screening in the Medicare population. Arch Intern Med. 2007; 167: 258264.
  • 22
    Cooper GS,Koroukian SM. Racial disparities in the use of and indications for colorectal procedures in Medicare beneficiaries. Cancer. 2004; 100: 418424.
  • 23
    Rabeneck L,Paszat LF. A population-based estimate of the extent of colorectal cancer screening in Ontario. Am J Gastroenterol. 2004; 99: 11411144.
    Direct Link: